infertility

Patients

pharmaphorum with Repronovo's Jean Duvall during JPM2026

Bringing parity to infertility, with Jean Duvall

During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.

R&D

pharmaphorum podcast episode 132a - woman on her phone listening to headphones

In vitro gametogenesis: the science has to be right, and it ...

In vitro gametogenesis (IVG) holds much potential for same-sex couples and women of a more advanced age struggling with infertility, but the question is whether we’re quite there yet.

News

Bayer pledges $2.2bn to US manufacturing facility

Bayer has joined the ranks of pharma groups planning major facility investments in the US, with a $2.2bn plan for a new production unit in Ohio.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks